Bruno A. Costa and Tarek Mouhieddine
Dec 9, 2024, 20:00
Bruno A. Costa: Outstanding presentation by Tarek Mouhieddine Institute on combined PD-1 and Tim-3 blockade to enhance anti-myeloma T cell activity
Bruno A. Costa, Palliative Care Fellow at Mount Sinai Health System, posted on X:
“Outstanding presentation by Tarek Mouhieddine from The Tisch Cancer Institute on combined PD-1 and Tim-3 blockade to enhance anti-myeloma T cell activity in patients receiving talquetamab.
Translational insights into GPRC5D and T cell dynamics during BsAb therapy with exciting clinical applicability.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 12, 2025, 13:47
Jan 12, 2025, 12:59
Jan 12, 2025, 12:33
Jan 12, 2025, 12:30
Jan 12, 2025, 12:17
Jan 12, 2025, 11:50